| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |